Endometrioma Sclerotherapy and Ovarian Preservation: a Randomised Control Trial of Laparoscopic Sclerotherapy vs Traditional Excision of Endometrioma

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A randomised controlled trial assessing ovarian reserve after laparoscopic ethanol sclerotherapy of ovarian endometrioma compared to standard treatment of surgical excision of endometrioma. Secondary outcomes will include endometrioma recurrence, symptomatology and inflammatory environment.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: f
View:

• Female (XX genotype, assigned female at birth)

• Age 18-40

• Finding of suspected uni- or bi-lateral ovarian endometrioma(ta) of ≥ 2cm on TVUSS and/or pelvic MRI scan (TVUSS, a uni- or multi-locular ovarian cystic lesion with low level echoes and diffuse homogeneous ground glass appearance; MRI any of, ovarian lesion hyperintense T1 without loss of signal on T1 fat-suppressed images, hypointense T2 exhibiting shading sign and/or T2 dark spot sign, variable restricted diffusion on DWI)

• Appropriate to be listed for laparoscopic excision of endometrioma (Endometrioma ≥2cm, pain symptoms attributable to endometriosis where medical management is unsuccessful or unacceptable to the patient, to facilitate ART)

Locations
Other Locations
United Kingdom
Chelsea and Westminster NHS Foundation Trust
RECRUITING
London
Contact Information
Primary
Sarah Bennet, BSc MBBS MRCOG
sarah.bennet25@imperial.ac.uk
07983980924
Backup
Thomas Bainton, BM BCh MRCOG MA(Oxon)
tombainton@doctors.org.uk
Time Frame
Start Date: 2025-02-21
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 60
Treatments
Other: Surgical Management of Endometrioma
Routine Care
Experimental: Laparoscopic Sclerotherapy
Laparoscopic ethanol sclerotherapy of endometrioma
Related Therapeutic Areas
Sponsors
Leads: Chelsea and Westminster NHS Foundation Trust

This content was sourced from clinicaltrials.gov